BIO-key International (NASDAQ:BKYI) Stock Gets Downgrade from Wall Street Zen

BIO-key International (NASDAQ:BKYI) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday, Wall Street Zen reports.

A number of other research analysts have also issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Thursday, October 15th. Zacks Research upgraded shares of BIO-key International to a “hold” rating in a report on Thursday, August 6th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce”.

BIO-key International Stock Performance

NASDAQ BKYI opened at $2.12 on Friday. BIO-key International has a one year low of $1.55 and a one year high of $10.70. The company has a 50-day simple moving average of $2.46 and a 200-day simple moving average of $4.40. The firm has a market capitalization of $4.31 million, a PE ratio of -0.52 and a beta of 0.52.

BIO-key International (NASDAQ:BKYI) last released its quarterly earnings data on Friday, November 13th. The technology company reported ($4.01) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($3.66). BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. The business had revenue of $1.48 million for the quarter, compared to analyst estimates of $2.40 million. Equities analysts forecast that BIO-key International will post -1.62 earnings per share for the current year.

About BIO-key International

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.